Liquid Biopsy
News and reporting on cell-free DNA testing.
Freenome Nets $290M Investment From Roche
The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types.
Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference
The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent.
NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark
NeoGenomics subsidiary Inivata has also submitted the RaDaR test to the MolDx program in the US for reimbursement.
Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test
PINC AI plans to adapt its clinical decision support platform to alert clinicians to patients who may benefit from early cancer detection via Galleri.
The company plans to launch an early access program for its DefineMBC assay in April, followed by a full commercial launch later in the year.
Jan 5, 2022
Nucleix Raises Additional $22M
Dec 17, 2021
Dec 9, 2021
PetDx Raises $62M in Series B Round
Dec 7, 2021